These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12866713)

  • 21. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor.
    Gardier AM
    Behav Pharmacol; 2009 Feb; 20(1):18-32. PubMed ID: 19179848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
    Duman CH; Schlesinger L; Kodama M; Russell DS; Duman RS
    Biol Psychiatry; 2007 Mar; 61(5):661-70. PubMed ID: 16945347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
    Pucak ML; Kaplin AI
    Int Rev Psychiatry; 2005 Dec; 17(6):477-83. PubMed ID: 16401546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies.
    Kozisek ME; Middlemas D; Bylund DB
    Pharmacol Ther; 2008 Jan; 117(1):30-51. PubMed ID: 17949819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
    Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erectile dysfunction in depression and under treatment with antidepressants -- current treatment options].
    Walther S; Mahlberg R
    Fortschr Neurol Psychiatr; 2006 Feb; 74(2):71-6. PubMed ID: 16485218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.
    Nutt DJ; Baldwin DS; Clayton AH; Elgie R; Lecrubier Y; Montejo AL; Papakostas GI; Souery D; Trivedi MH; Tylee A
    J Clin Psychiatry; 2006; 67 Suppl 6():46-9. PubMed ID: 16848678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc: the new antidepressant?
    Levenson CW
    Nutr Rev; 2006 Jan; 64(1):39-42. PubMed ID: 16491668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurogenesis: a novel strategy for the treatment of depression].
    Zhang LM; Li YF; Gong ZH
    Sheng Li Ke Xue Jin Zhan; 2005 Apr; 36(2):109-12. PubMed ID: 16222968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research progress on therapeutic mechanism of depression treated by traditional chinese medicine].
    Mao QQ; Huang Z
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):877-80. PubMed ID: 17655134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How antidepressants help depression: mechanisms of action and clinical response.
    Delgado PL
    J Clin Psychiatry; 2004; 65 Suppl 4():25-30. PubMed ID: 15046538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of depression: challenges from a drug development perspective.
    Rupniak NM
    Behav Pharmacol; 2003 Sep; 14(5-6):385-90. PubMed ID: 14501252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models of depression: navigating through the clinical fog.
    Matthews K; Christmas D; Swan J; Sorrell E
    Neurosci Biobehav Rev; 2005; 29(4-5):503-13. PubMed ID: 15925695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants and pain.
    Micó JA; Ardid D; Berrocoso E; Eschalier A
    Trends Pharmacol Sci; 2006 Jul; 27(7):348-54. PubMed ID: 16762426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invivo antioxidant status: a putative target of antidepressant action.
    Zafir A; Ara A; Banu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.